Association between advanced glycation end products (AGEs) and diabetic complications: A systematic review and meta-analysis

Closed

Anditri Weningtyas, Victor Alvianoes Guterez Hose, Dian Nugrahenny, Achmad Rudijanto, Mohammad Saifur Rohman

2026 Diabetes Research and Clinical Practice Vol. 239 Review Cited by 0 Quartile

Abstract

Diabetes mellitus is characterized by chronic hyperglycemia, which accelerates the accumulation of advanced glycation end products (AGEs), contributing to vascular complications through oxidative stress and inflammation, though clinical evidence remains heterogeneous. This systematic review and meta-analysis searched PubMed, Embase, Scopus, and Web of Science for observational studies evaluating AGEs in diabetes. To resolve methodological variations, analyses were stratified by modality: tissue-bound AGEs via skin autofluorescence (sAF) and circulating isoforms, specifically Nε-carboxymethyllysine (CML). Fifteen studies (6,288 participants) were included. Patients with complications had significantly higher AGE levels than those without (pooled MD = 0.29 AU; 95% CI: 0.23–0.36; I2 = 71%). Subgroup analyses revealed that tissue-bound sAF was consistently elevated across all microvascular and macrovascular subtypes. Conversely, circulating CML demonstrated a highly selective, robust association with macrovascular outcomes (MD = 20.24 µmol/mol lys; 95% CI: 7.19–33.29) but no significant link with microvascular angiopathy. Overall, elevated AGEs are consistently associated with diabetic complications. Tissue-bound sAF serves as a versatile clinical biomarker for global end-organ damage, whereas circulating CML acts as a distinct indicator of macrovascular risk. © 2026 Elsevier B.V.

Affiliations

Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Medicine, Faculty of Medicine, Universitas Negeri Malang, Malang, Indonesia; Cardiovascular Research Centre, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia